Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 82 clinical trials
TMAO in Patients With Severe Aortic Stenosis

Trimethylamine N-oxide (TMAO) has recently gained increasing scientific interest in the field of cardiovascular disease, including its role in cell protection against osmotic and hydrostatic stress. Aortic stenosis (AS) is the most common valvular heart disease, affecting about 7.6 million people over 75 years of age in North America and …

stenosis
cardiovascular disease
aortic stenosis
heart failure
aortic valve replacement
  • 0 views
  • 19 Feb, 2024
Change of NLRP3 Inflammasome Expression Level Symptoms and Functional Status in HFpEF Patients Treated With ARNI

Underlying inflammation has been increasingly recognized in heart failure with a preserved ejection fraction(HFpEF). But there is no study reported the relationship between NLRP3 inflammasome and HFpEF. In this study, investigators propose a scientific hypothesis that the expression of NLRP3 inflammasome is elevated in patients with HFpEF, and the level …

sacubitril
n-terminal pro-bnp
ntprobnp
diastolic dysfunction
heart disease
  • 0 views
  • 19 Feb, 2024
Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator

Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.

ejection fraction
cardiomyopathy
  • 0 views
  • 19 Feb, 2024
Reduction or Extension of COnduction Time With Ventricular Electromechanical Remodeling (RECOVER)

This prospective multicenter registry study aims to detect the serial changes in ventriculo-ventricular conduction times according to cardiac-resynchronization therapy response.

  • 0 views
  • 19 Feb, 2024
COronary and MICrocirculatory Measurements in Patients With Aortic Valve Stenosis.

Aortic stenosis (AS) is the most common primary valve disease leading to surgery or catheter intervention in Europe, with a growing prevalence due to the aging population. Severe AS is associated with significant morbidity and mortality and is treated by surgical valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI). …

stenosis
aortic stenosis
fractional flow reserve (ffr)
tavi
ct scan
  • 0 views
  • 19 Feb, 2024
SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement

The purpose of this study is to observe conduction disturbance, daily activity level, heart rates, oxygen saturation in patients who underwent Transcatheter Aortic Valve Replacement (TAVR) and to evaluate the utility of the HUAWEI Watch (HUAWEI Technologies Co., Ltd., Shenzhen, China) for the potential early warning sign of changes in …

stenosis
aortic stenosis
oxygen saturation
transcatheter aortic valve implantation
aortic valve replacement
  • 0 views
  • 19 Feb, 2024
VitaFlow Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

The study objective is to evaluate safety and effectiveness/performance of the Microport CardioFlow VitaFlow Transcatheter Aortic Valve System for the treatment of severe aortic stenosis in the real world settings.

aortic stenosis
aortic valve replacement
stenosis
  • 0 views
  • 19 Feb, 2024
MiCLASP Post Market Clinical Follow-Up (PMCF) Study

This is a postmarket clinical follow up study on the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in transcatheter mitral valve repair.

mitral valve repair
regurgitation
walk test
  • 0 views
  • 19 Feb, 2024
3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation

The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk stratification and cardiovascular outcome in patients with mitral regurgitation of different etiologies.

regurgitation
heart failure
ejection fraction
  • 0 views
  • 19 Feb, 2024
Sequelae of Sars-CoV-2 Infections

By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy. To date, no vaccine or therapy is available. Severe courses of the …

cardiovascular system
acute respiratory syndrome (sars)
pneumonia
coronavirus infection
  • 0 views
  • 19 Feb, 2024